A New Life-Long Hemorrhagic Disorder Due to Excess Plasminogen Activator
A life-long bleeding disorder is described, characterized by hemorrhage occurring after surgery, injury, or dental extraction, and finally by spontaneous intracerebral bleeding. No abnormality of platelet function or plasma coagulation was demonstrable, but grossly enhanced overall fibrinolytic acti...
Gespeichert in:
Veröffentlicht in: | Blood 1983-02, Vol.61 (2), p.267-275 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 275 |
---|---|
container_issue | 2 |
container_start_page | 267 |
container_title | Blood |
container_volume | 61 |
creator | Booth, N.A. Bennett, B. Wijngaards, G. Grieve, J.H.K. |
description | A life-long bleeding disorder is described, characterized by hemorrhage occurring after surgery, injury, or dental extraction, and finally by spontaneous intracerebral bleeding. No abnormality of platelet function or plasma coagulation was demonstrable, but grossly enhanced overall fibrinolytic activity was present. The patient had, additionally, a hyperlipidemia with gross arterial atheroma and a family history of myocardial infarction but not of any hemorrhagic disorder. Laboratory studies led to the conclusion that the enhanced fibrinolysis was due to consistently greatly raised levels of a plasma plasminogen activator physically and immunologically related to that in human tissues and blood vessel endothelium. No deficiency of any known inhibitor of fibrinolysis was detected. Free plasmin was not detectable in functional assays but continuous intravascular plasmin generation clearly occurred as evidenced by presence of plasmin-α2-antiplasmin complexes and of fibrin/fibrinogen-related antigens. Excessive production of plasminogen activator appeared to have occurred throughout life and to be independent of the hyperlipidemia. The pathologically increased fibrinolytic activity may have accounted for the complete absence of detectable thrombotic vascular occlusion at autopsy despite extensive arterial disease with severe narrowing of coronary and cerebral arteries. |
doi_str_mv | 10.1182/blood.V61.2.267.267 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80355400</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497120809264</els_id><sourcerecordid>80355400</sourcerecordid><originalsourceid>FETCH-LOGICAL-c399t-2a0a57fd8b66764fb28116118605c97518f74acbed451c6242a10a73e7f5b7b63</originalsourceid><addsrcrecordid>eNp9kD9PwzAUxC0EKqXwCRCSJ7YU24n_dGCoaKFIFTAAq-U4L8UoiYudFPj2pLRiZDi94d2ddD-EzikZU6rYVV55X4xfBR2zMRNyqwM0pJyphBBGDtGQECKSbCLpMTqJ8Z0QmqWMD9BACEW5UkO0mOIH-MRLV0Ky9M0KL6D2IbyZlbN45qIPBQQ86wC3Hs-_LMSInyoTa9f4FTR4alu3Ma0Pp-ioNFWEs_0doZfb-fPNIlk-3t3fTJeJTSeTNmGGGC7LQuVCSJGVOVOUin6OINxOJKeqlJmxORQZp1awjBlKjExBljyXuUhH6HLXuw7-o4PY6tpFC1VlGvBd1IqknGeE9MZ0Z7TBxxig1OvgahO-NSV6y0__8tM9P810z26rPnWxr-_yGoq_zB5Y_7_e_aHfuHEQdLQOGguFC2BbXXj3b_8Pw-GAiA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80355400</pqid></control><display><type>article</type><title>A New Life-Long Hemorrhagic Disorder Due to Excess Plasminogen Activator</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Booth, N.A. ; Bennett, B. ; Wijngaards, G. ; Grieve, J.H.K.</creator><creatorcontrib>Booth, N.A. ; Bennett, B. ; Wijngaards, G. ; Grieve, J.H.K.</creatorcontrib><description>A life-long bleeding disorder is described, characterized by hemorrhage occurring after surgery, injury, or dental extraction, and finally by spontaneous intracerebral bleeding. No abnormality of platelet function or plasma coagulation was demonstrable, but grossly enhanced overall fibrinolytic activity was present. The patient had, additionally, a hyperlipidemia with gross arterial atheroma and a family history of myocardial infarction but not of any hemorrhagic disorder. Laboratory studies led to the conclusion that the enhanced fibrinolysis was due to consistently greatly raised levels of a plasma plasminogen activator physically and immunologically related to that in human tissues and blood vessel endothelium. No deficiency of any known inhibitor of fibrinolysis was detected. Free plasmin was not detectable in functional assays but continuous intravascular plasmin generation clearly occurred as evidenced by presence of plasmin-α2-antiplasmin complexes and of fibrin/fibrinogen-related antigens. Excessive production of plasminogen activator appeared to have occurred throughout life and to be independent of the hyperlipidemia. The pathologically increased fibrinolytic activity may have accounted for the complete absence of detectable thrombotic vascular occlusion at autopsy despite extensive arterial disease with severe narrowing of coronary and cerebral arteries.</description><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood.V61.2.267.267</identifier><identifier>PMID: 6681588</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>alpha-2-Antiplasmin - immunology ; Blood Coagulation Tests ; Cerebral Hemorrhage - complications ; Fibrinolysis ; Hematoma - etiology ; Hemorrhagic Disorders - complications ; Hemorrhagic Disorders - etiology ; Humans ; Hyperlipidemias - complications ; Hyperlipidemias - genetics ; Immunoelectrophoresis ; Male ; Middle Aged ; Plasminogen Activators - biosynthesis</subject><ispartof>Blood, 1983-02, Vol.61 (2), p.267-275</ispartof><rights>1983 American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c399t-2a0a57fd8b66764fb28116118605c97518f74acbed451c6242a10a73e7f5b7b63</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6681588$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Booth, N.A.</creatorcontrib><creatorcontrib>Bennett, B.</creatorcontrib><creatorcontrib>Wijngaards, G.</creatorcontrib><creatorcontrib>Grieve, J.H.K.</creatorcontrib><title>A New Life-Long Hemorrhagic Disorder Due to Excess Plasminogen Activator</title><title>Blood</title><addtitle>Blood</addtitle><description>A life-long bleeding disorder is described, characterized by hemorrhage occurring after surgery, injury, or dental extraction, and finally by spontaneous intracerebral bleeding. No abnormality of platelet function or plasma coagulation was demonstrable, but grossly enhanced overall fibrinolytic activity was present. The patient had, additionally, a hyperlipidemia with gross arterial atheroma and a family history of myocardial infarction but not of any hemorrhagic disorder. Laboratory studies led to the conclusion that the enhanced fibrinolysis was due to consistently greatly raised levels of a plasma plasminogen activator physically and immunologically related to that in human tissues and blood vessel endothelium. No deficiency of any known inhibitor of fibrinolysis was detected. Free plasmin was not detectable in functional assays but continuous intravascular plasmin generation clearly occurred as evidenced by presence of plasmin-α2-antiplasmin complexes and of fibrin/fibrinogen-related antigens. Excessive production of plasminogen activator appeared to have occurred throughout life and to be independent of the hyperlipidemia. The pathologically increased fibrinolytic activity may have accounted for the complete absence of detectable thrombotic vascular occlusion at autopsy despite extensive arterial disease with severe narrowing of coronary and cerebral arteries.</description><subject>alpha-2-Antiplasmin - immunology</subject><subject>Blood Coagulation Tests</subject><subject>Cerebral Hemorrhage - complications</subject><subject>Fibrinolysis</subject><subject>Hematoma - etiology</subject><subject>Hemorrhagic Disorders - complications</subject><subject>Hemorrhagic Disorders - etiology</subject><subject>Humans</subject><subject>Hyperlipidemias - complications</subject><subject>Hyperlipidemias - genetics</subject><subject>Immunoelectrophoresis</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Plasminogen Activators - biosynthesis</subject><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1983</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kD9PwzAUxC0EKqXwCRCSJ7YU24n_dGCoaKFIFTAAq-U4L8UoiYudFPj2pLRiZDi94d2ddD-EzikZU6rYVV55X4xfBR2zMRNyqwM0pJyphBBGDtGQECKSbCLpMTqJ8Z0QmqWMD9BACEW5UkO0mOIH-MRLV0Ky9M0KL6D2IbyZlbN45qIPBQQ86wC3Hs-_LMSInyoTa9f4FTR4alu3Ma0Pp-ioNFWEs_0doZfb-fPNIlk-3t3fTJeJTSeTNmGGGC7LQuVCSJGVOVOUin6OINxOJKeqlJmxORQZp1awjBlKjExBljyXuUhH6HLXuw7-o4PY6tpFC1VlGvBd1IqknGeE9MZ0Z7TBxxig1OvgahO-NSV6y0__8tM9P810z26rPnWxr-_yGoq_zB5Y_7_e_aHfuHEQdLQOGguFC2BbXXj3b_8Pw-GAiA</recordid><startdate>198302</startdate><enddate>198302</enddate><creator>Booth, N.A.</creator><creator>Bennett, B.</creator><creator>Wijngaards, G.</creator><creator>Grieve, J.H.K.</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198302</creationdate><title>A New Life-Long Hemorrhagic Disorder Due to Excess Plasminogen Activator</title><author>Booth, N.A. ; Bennett, B. ; Wijngaards, G. ; Grieve, J.H.K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c399t-2a0a57fd8b66764fb28116118605c97518f74acbed451c6242a10a73e7f5b7b63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1983</creationdate><topic>alpha-2-Antiplasmin - immunology</topic><topic>Blood Coagulation Tests</topic><topic>Cerebral Hemorrhage - complications</topic><topic>Fibrinolysis</topic><topic>Hematoma - etiology</topic><topic>Hemorrhagic Disorders - complications</topic><topic>Hemorrhagic Disorders - etiology</topic><topic>Humans</topic><topic>Hyperlipidemias - complications</topic><topic>Hyperlipidemias - genetics</topic><topic>Immunoelectrophoresis</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Plasminogen Activators - biosynthesis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Booth, N.A.</creatorcontrib><creatorcontrib>Bennett, B.</creatorcontrib><creatorcontrib>Wijngaards, G.</creatorcontrib><creatorcontrib>Grieve, J.H.K.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Booth, N.A.</au><au>Bennett, B.</au><au>Wijngaards, G.</au><au>Grieve, J.H.K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A New Life-Long Hemorrhagic Disorder Due to Excess Plasminogen Activator</atitle><jtitle>Blood</jtitle><addtitle>Blood</addtitle><date>1983-02</date><risdate>1983</risdate><volume>61</volume><issue>2</issue><spage>267</spage><epage>275</epage><pages>267-275</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><abstract>A life-long bleeding disorder is described, characterized by hemorrhage occurring after surgery, injury, or dental extraction, and finally by spontaneous intracerebral bleeding. No abnormality of platelet function or plasma coagulation was demonstrable, but grossly enhanced overall fibrinolytic activity was present. The patient had, additionally, a hyperlipidemia with gross arterial atheroma and a family history of myocardial infarction but not of any hemorrhagic disorder. Laboratory studies led to the conclusion that the enhanced fibrinolysis was due to consistently greatly raised levels of a plasma plasminogen activator physically and immunologically related to that in human tissues and blood vessel endothelium. No deficiency of any known inhibitor of fibrinolysis was detected. Free plasmin was not detectable in functional assays but continuous intravascular plasmin generation clearly occurred as evidenced by presence of plasmin-α2-antiplasmin complexes and of fibrin/fibrinogen-related antigens. Excessive production of plasminogen activator appeared to have occurred throughout life and to be independent of the hyperlipidemia. The pathologically increased fibrinolytic activity may have accounted for the complete absence of detectable thrombotic vascular occlusion at autopsy despite extensive arterial disease with severe narrowing of coronary and cerebral arteries.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>6681588</pmid><doi>10.1182/blood.V61.2.267.267</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-4971 |
ispartof | Blood, 1983-02, Vol.61 (2), p.267-275 |
issn | 0006-4971 1528-0020 |
language | eng |
recordid | cdi_proquest_miscellaneous_80355400 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | alpha-2-Antiplasmin - immunology Blood Coagulation Tests Cerebral Hemorrhage - complications Fibrinolysis Hematoma - etiology Hemorrhagic Disorders - complications Hemorrhagic Disorders - etiology Humans Hyperlipidemias - complications Hyperlipidemias - genetics Immunoelectrophoresis Male Middle Aged Plasminogen Activators - biosynthesis |
title | A New Life-Long Hemorrhagic Disorder Due to Excess Plasminogen Activator |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T11%3A56%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20New%20Life-Long%20Hemorrhagic%20Disorder%20Due%20to%20Excess%20Plasminogen%20Activator&rft.jtitle=Blood&rft.au=Booth,%20N.A.&rft.date=1983-02&rft.volume=61&rft.issue=2&rft.spage=267&rft.epage=275&rft.pages=267-275&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood.V61.2.267.267&rft_dat=%3Cproquest_cross%3E80355400%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80355400&rft_id=info:pmid/6681588&rft_els_id=S0006497120809264&rfr_iscdi=true |